Transcription factor NRF2 as a key modulator of immune response

Summary. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that plays a crucial role in immune regulation by promoting antioxidant defences, modulating inflammation, supporting immune cell function, and influencing autoimmune responses. Dysregulation of NRF2 signalling is implicated in the pathogenesis of autoimmune diseases and chronic inflammatory conditions. NRF2 activators, through their anti-inflammatory and antioxidant properties, have shown potential therapeutic benefits in preclinical and clinical studies for diseases characterised by dysregulated inflammation and oxidative stress such as multiple sclerosis (MS). MS is an autoimmune, neurodegenerative, and inflammatory disease of the central nervous system (CNS). In our model of MS, experimental autoimmune encephalomyelitis (EAE), we have investigated the role of NRF2 activators on several immune cell types important for the pathology of CNS autoimmunity. Ethyl pyruvate (EP), a redox analogue of MS drug dimethyl fumarate, has been proven to have beneficial effects in EAE, by suppressing encephalitogenic T cells and macrophages and inducing tolerogenic properties in dendritic cells (DCs). In a recent study, we have shown that EP achieves its effects in DCs by increasing the expression of several NRF2 downstream genes and by decreasing the expression of NF-kB genes, suggesting that the tolerogenic effect of EP is achieved through the activation of the NRF2 signalling pathway. Another tested substance, named SB140, is a derivative of cholic bile acid. This compound was tested in immune cells implicated in the pathogenesis of EAE: microglia and encephalitogenic T cells, and it was shown to have anti-inflammatory effects. These results demonstrate that both agents have potent immunomodulatory effects and suggest that they act as NRF2 activators. Both EP and SB140 are indicated as promising therapeutics in MS, but also in other diseases mediated by inflammation and oxidative stress, and thus, their role should be further investigated.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-23
DOI
https://doi.org/10.5281/zenodo.14537277
Primary Topic
Genomics, phytochemicals, and oxidative stress
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Transcription factor NRF2 as a key modulator of immune response

Zenodo (CERN European Organization for Nuclear Research)
Genomics, phytochemicals, and oxidative stress
article

Transcription factor NRF2 as a key modulator of immune response

article en

Abstract

Summary. Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor that plays a crucial role in immune regulation by promoting antioxidant defences, modulating inflammation, supporting immune cell function, and influencing autoimmune responses. Dysregulation of NRF2 signalling is implicated in the pathogenesis of autoimmune diseases and chronic inflammatory conditions. NRF2 activators, through their anti-inflammatory and antioxidant properties, have shown potential therapeutic benefits in preclinical and clinical studies for diseases characterised by dysregulated inflammation and oxidative stress such as multiple sclerosis (MS). MS is an autoimmune, neurodegenerative, and inflammatory disease of the central nervous system (CNS). In our model of MS, experimental autoimmune encephalomyelitis (EAE), we have investigated the role of NRF2 activators on several immune cell types important for the pathology of CNS autoimmunity. Ethyl pyruvate (EP), a redox analogue of MS drug dimethyl fumarate, has been proven to have beneficial effects in EAE, by suppressing encephalitogenic T cells and macrophages and inducing tolerogenic properties in dendritic cells (DCs). In a recent study, we have shown that EP achieves its effects in DCs by increasing the expression of several NRF2 downstream genes and by decreasing the expression of NF-kB genes, suggesting that the tolerogenic effect of EP is achieved through the activation of the NRF2 signalling pathway. Another tested substance, named SB140, is a derivative of cholic bile acid. This compound was tested in immune cells implicated in the pathogenesis of EAE: microglia and encephalitogenic T cells, and it was shown to have anti-inflammatory effects. These results demonstrate that both agents have potent immunomodulatory effects and suggest that they act as NRF2 activators. Both EP and SB140 are indicated as promising therapeutics in MS, but also in other diseases mediated by inflammation and oxidative stress, and thus, their role should be further investigated.

Zenodo (CERN European Organization for Nuclear Research)
University of Belgrade (RS), Institute of Physics Belgrade (RS)
Good health and well-being
Openalex Percentile: Top 75%
Genomics, phytochemicals, and oxidative stress
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Transcription factor NRF2 as a key modulator of immune response · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS